Boosters Effectively Fend Off Delta, Omicron Variants in Studies

Bloomberg Quicktake: Now published this video item, entitled “Boosters Effectively Fend Off Delta, Omicron Variants in Studies” – below is their description.

Booster doses of Covid-19 vaccines increased protection against both the delta and omicron variants in three studies that looked at infections, hospital admissions and deaths in thousands of U.S. patients.

Third doses of messenger RNA vaccines made by Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE were at least 90% effective in preventing hospitalizations during both the delta and omicron periods, according to an analysis of hundreds of thousands of hospitalizations and clinic visits. The shots’ protection against Covid deaths was diminished after omicron’s rise, but remained significant, according to a separate study from the U.S. Centers for Disease Control and Prevention.

Bloomberg Quicktake: Now YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - Bloomberg QuickTake: Now

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake: Now:

Biden Departs White House En Route to Buffalo

Amber Heard Says Violence Became ‘Normal’ in Johnny Depp Case

Buffalo Shooting Suspect Visited Supermarket Before Attack: Police

In This Story: BioNTech

BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

5 Recent Items: BioNTech

Biden Gets His Second Covid Booster Shot

Europe refuses to drop vaccine patents, offering mobile vaccine plants instead | DW News

BioNTech to ship vaccine factory kits to Africa | DW News

Pfizer-BioNTech Co-Founders Give Exclusive Look Into Covid-19 Vaccine

Fact check: Does the omicron variant reduce vaccine efficacy? | DW News

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

More trains depart from Shanghai as resurgence of COVID-19 wanes

Shanghai reaches zero-COVID status, Ruijin Hospital resumes normal operations

China’s fiscal reform aims to improve business environment

LIVE: Media on COVID-19 and other global health issues

United Airlines CEO Scott Kirby on Covid: We are out of the tunnel

In This Story: Moderna

Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

CEO: Stéphane Bancel (2011–)

Stock ticker: (NASDAQ:MRNA)

5 Recent Items: Moderna

Karen Firestone’s top stock picks: Vertex Pharma, Moderna

Fears of flu spread over winter as TGA considers approval of Moderna vaccine for under-6s | 7NEWS

Biden Hosts Virtual COVID-19 Summit, 1989 (Taylor’s Version) Clues | The Tonight Show

SoftBank fund posts $27B loss, Moderna CFO ousted, Abbott could restart baby formula production

Nike claims StockX is selling fake shoes, Beyond Meat stock slumps, Moderna CFO steps down

In This Story: Omicron

The Omicron variant of Covid-19 (also known as B.1.1.529) has been declared a Variant of Concern.

The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variant: B.1.1.529 – which is known as Omicron – the group declared the variant a Variant of Concern.

5 Recent Items: Omicron

Kim Jong-un warns Covid posing ‘great turmoil’ on North Korea as deadly outbreak quickly spreads

North Korea confirms 1st COVID-19 deaths days after admitting 1st outbreak

North Korea confirms first Covid-19 death in ‘explosive’ outbreak • FRANCE 24 English

North Korea reports first official COVID-19 death | DW News

North Korea confirms COVID-19 outbreak, imposes nationwide lockdown

In This Story: Pfizer

Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

5 Recent Items: Pfizer

Biohaven CEO discusses Pfizer’s purchase of the company

Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company

Pfizer acquires Biohaven for $11.6 billion in cash

We’re Not Allowed To Talk About This

Pfizer will submit data on Covid-19 vaccine for kids under 5 in next few weeks, says CEO Bourla

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.

Posting....